GET THE APP

Trastuzumab | Open Access Journals
..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Trastuzumab

Trastuzumab, marketed under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. The HER2 receptor positive is primarily used for cancer. It may be used alone or in combination with other chemotherapy medications. Trastuzumab is administered by slow injection into a vein and injection just below the skin. Common side effects include headache, fever, cough, sleeping disorders, infections, and rash. Use during pregnancy can harm the baby. Trastuzumab works by binding to the receptor HER2 and slowing down duplication of the cells.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward